Prevalence of ecstasy-type substances use percent of population aged 15-64, 2000–2016 Info Edit Download | Share Twitter Facebook LinkedIn Reddit Email World Map Line Chart Bar Chart Tree Map Rank List Calc Table Data Table Select Country/Region -- Albania Algeria Argentina Armenia Australia Austria Bahamas Barbados Belarus Belgium Belize Bolivia Bosnia and Herzegovina Brazil Bulgaria Cambodia Canada Cape Verde Chile Hong Kong Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador El Salvador Estonia Finland France Georgia Germany Greece Guatemala Guyana Haiti Honduras Hungary Iceland Indonesia Ireland Israel Italy Jamaica Japan Kenya South Korea Latvia Lebanon Lithuania Luxembourg Macedonia (F.Y.R.O.M.) Malaysia Malta Mexico Moldova Montenegro Netherlands New Zealand Nicaragua Norway Panama Paraguay Peru Philippines Poland Portugal Puerto Rico Romania Russia Saint Lucia Serbia Slovakia Slovenia South Africa Spain Suriname Sweden Switzerland Taiwan Thailand Trinidad and Tobago Turkey Ukraine England and Wales Northern Ireland Scotland United States Uruguay Venezuela Vietnam Zambia Advanced Economies (IMF) Africa (IMF) ASEAN-5 (IMF) Asia & Pacific (IMF) Australia & New Zealand (IMF) Australia & New Zealand (UN) Caribbean (IMF) Caribbean (UN) Central America (IMF) Central America (UN) Central Asia (UN) Central Asia & Caucasus (IMF) Commonwealth of Independent States (IMF) Developed Countries (UN) Developing Countries (UN) East Asia (IMF) East Asia & Pacific (World Bank) Eastern Africa (UN) Eastern Asia (UN) Eastern Europe (IMF) Eastern Europe (UN) Emerging & Developing Asia (IMF) Emerging & Developing Economies (IMF) Emerging & Developing Europe (IMF) Euro Area (IMF) Europe (IMF) Europe & Central Asia (World Bank) European Union (IMF) High Income (World Bank) Latin America & Caribbean (IMF) Latin America & Caribbean (UN) Latin America & Caribbean (World Bank) Least Developed Countries (UN) Low Income (World Bank) Lower Middle Income (World Bank) Major Advanced Economies (IMF) Melanesia (UN) Micronesia (UN) Middle Africa (UN) Middle East (IMF) Middle East & North Africa (World Bank) Middle East, North Africa, Afghanistan & Pakistan (IMF) North Africa (IMF) North America (IMF) North America (World Bank) Northern Africa (UN) Northern America (UN) Northern Europe (UN) Other Advanced Economies (IMF) Pacific Islands (IMF) Polynesia (UN) South America (IMF) South America (UN) South Asia (IMF) South Asia (World Bank) South-Eastern Asia (UN) Southeast Asia (IMF) Southern Africa (UN) Southern Asia (UN) Southern Europe (UN) Sub-Saharan Africa (IMF) Sub-Saharan Africa (UN) Sub-Saharan Africa (World Bank) Sub-Saharan Africa – analytical (IMF) Upper Middle Income (World Bank) Western Africa (UN) Western Asia (UN) Western Europe (IMF) Western Europe (UN) Western Hemisphere (IMF) World Select Country/Region -- Albania Algeria Argentina Armenia Australia Austria Bahamas Barbados Belarus Belgium Belize Bolivia Bosnia and Herzegovina Brazil Bulgaria Cambodia Canada Cape Verde Chile Hong Kong Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador El Salvador Estonia Finland France Georgia Germany Greece Guatemala Guyana Haiti Honduras Hungary Iceland Indonesia Ireland Israel Italy Jamaica Japan Kenya South Korea Latvia Lebanon Lithuania Luxembourg Macedonia (F.Y.R.O.M.) Malaysia Malta Mexico Moldova Montenegro Netherlands New Zealand Nicaragua Norway Panama Paraguay Peru Philippines Poland Portugal Puerto Rico Romania Russia Saint Lucia Serbia Slovakia Slovenia South Africa Spain Suriname Sweden Switzerland Taiwan Thailand Trinidad and Tobago Turkey Ukraine England and Wales Northern Ireland Scotland United States Uruguay Venezuela Vietnam Zambia Advanced Economies (IMF) Africa (IMF) ASEAN-5 (IMF) Asia & Pacific (IMF) Australia & New Zealand (IMF) Australia & New Zealand (UN) Caribbean (IMF) Caribbean (UN) Central America (IMF) Central America (UN) Central Asia (UN) Central Asia & Caucasus (IMF) Commonwealth of Independent States (IMF) Developed Countries (UN) Developing Countries (UN) East Asia (IMF) East Asia & Pacific (World Bank) Eastern Africa (UN) Eastern Asia (UN) Eastern Europe (IMF) Eastern Europe (UN) Emerging & Developing Asia (IMF) Emerging & Developing Economies (IMF) Emerging & Developing Europe (IMF) Euro Area (IMF) Europe (IMF) Europe & Central Asia (World Bank) European Union (IMF) High Income (World Bank) Latin America & Caribbean (IMF) Latin America & Caribbean (UN) Latin America & Caribbean (World Bank) Least Developed Countries (UN) Low Income (World Bank) Lower Middle Income (World Bank) Major Advanced Economies (IMF) Melanesia (UN) Micronesia (UN) Middle Africa (UN) Middle East (IMF) Middle East & North Africa (World Bank) Middle East, North Africa, Afghanistan & Pakistan (IMF) North Africa (IMF) North America (IMF) North America (World Bank) Northern Africa (UN) Northern America (UN) Northern Europe (UN) Other Advanced Economies (IMF) Pacific Islands (IMF) Polynesia (UN) South America (IMF) South America (UN) South Asia (IMF) South Asia (World Bank) South-Eastern Asia (UN) Southeast Asia (IMF) Southern Africa (UN) Southern Asia (UN) Southern Europe (UN) Sub-Saharan Africa (IMF) Sub-Saharan Africa (UN) Sub-Saharan Africa (World Bank) Sub-Saharan Africa – analytical (IMF) Upper Middle Income (World Bank) Western Africa (UN) Western Asia (UN) Western Europe (IMF) Western Europe (UN) Western Hemisphere (IMF) World Select a starting year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Select an ending year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Related Drug Use Datasets Alcohol consumption, liters of pure alcohol per person, 1960–2015 Alcohol use deaths, per 100,000 people, 1990–2016 Alcohol use disorder prevalence, per 100,000 people, 1990–2016 Amphetamine use disorder deaths, per 100,000 people, 1990–2017 Amphetamine use disorder prevalence, per 100,000 people, 1990–2017 Cirrhosis and other chronic liver disease prevalence, per 100,000 people, 1990–2017 Cocaine use disorder deaths, per 100,000 people, 1990–2017 Cocaine use disorder prevalence, per 100,000 people, 1990–2017 Daily smokers, aged 15 and older, OECD, percent of population, 1960–2015 Daily smokers, women aged 15 and older, OECD, percent of population, 1960–2016 Drug use disorder prevalence, per 100,000 people, 1990–2017 Number of daily smokers, number, 1980–2012 Opioid use disorder deaths, per 100,000 people, 1990–2017 Prevalence of cannabis use, percent of population aged 15-64, 2000–2016 Prevalence of cocaine use, percent of population aged 15-64, 2002–2016 Prevalence of opioid use, percent of population aged 15-64, 2001–2015 Prevalence of tranquillizers and sedatives use, percent of population aged 15-64, 1998–2015 Smoking prevalence, percent of population, 1980–2012 General prevalence. “Ecstasyâ€-type substances include MDA, MDE/MDEA, and MDMA. Source: UNODC